http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1642577-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f7b665fb8f15d0e2b0911539d39f8a2 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04 |
filingDate | 2004-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_415ab1a7c6db652f877fe4758c1e89e0 |
publicationDate | 2006-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1642577-A1 |
titleOfInvention | Derivatives of aryl (or heteroaryl) azolylcarbinols for the treatment of central neuropathic pain |
abstract | The present invention refers to the use of derivatives of aryl (or heteroaryl) azolylcarbinols of general formula (I), and their physiologically acceptable salts, as medicinal products for human and/or animal therapeutics for the treatment of the symptoms of central neuropathic pain, especially certain subtypes of central neuropathic pain, as well as treatment of the disease causing the symptoms, the prevention or the prophylaxis of the symptoms of central neuropathic pain, especially certain subtypes of central neuropathic pain, as well as the prevention or the prophylaxis of the disease causing the symptoms. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016096127-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10071968-B2 |
priorityDate | 2004-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 879.